Delivery Order SPE2DE24D0013-SPE2D625F0SRM

The U.S. Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on August 11, 2025, for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This delivery order, with an ultimate completion date of August 18, 2025, carries no set-aside designation and represents a focused procurement of molecular diagnostic products or services from the Sunnyvale, California-based manufacturer. The award likely falls under one of Cepheid's existing Indefinite Delivery/Indefinite Quantity (IDIQ) vehicles, such as the company's significant $32.8 million single-award contract with the VA's Veterans Integrated Service Network 6 or the $2.5 million IDIQ with VISN 21, both of which support continuous procurement of molecular diagnostic testing systems and reagents through firm fixed-price delivery orders.

Cepheid specializes in molecular diagnostic solutions and GeneXpert systems designed to detect infectious diseases across federal healthcare systems. The company has established itself as a key supplier to the Department of Veterans Affairs, Defense Logistics Agency, and Defense Health Agency, providing comprehensive diagnostic equipment, reagents, testing services, and maintenance support. This delivery order aligns with the Defense Medical Supply Chain's operational requirements to maintain diagnostic capabilities for pandemic preparedness and respiratory illness detection across military and defense healthcare networks.